Intero Biosystems Wins TechCrunch Startup Battlefield 2026
Denver-based biotech startup secures top honors and $100,000 prize at Disrupt 2026.
1Disrupt 2026 Competition Overview
The Startup Battlefield at TechCrunch Disrupt 2026 concluded after three intense days in San Francisco. Twenty startups were selected from the Battlefield 200 to compete for the prestigious cup and a $100,000 cash prize. These companies presented live demonstrations to a panel of venture capitalists and prominent technology industry leaders.
2The Finalist Selection Process
TechCrunch editors reviewed judges' notes to narrow the field to five finalists: Apate, Flox Intelligence, Intero Biosystems, Industrial Next, and Satlyt. These companies faced a final panel including Alexa von Tobel of Inspired Capital and Chi-Hua Chien of Goodwater Capital. The deliberation process focused on innovation, market potential, and technical execution.
3Intero Biosystems Core Innovation
Winner Intero Biosystems is a Denver-based startup founded by Charlie Childs and Madeline Eiken. Originating from the University of Michigan, the company develops 1mm human intestinal organoids. This lab-grown tissue mimics the human gut, providing a sophisticated platform for pharmaceutical and biotech companies to test drug compounds before human clinical trials.
4GastroScreen Product Market Application
The startup commercializes its flagship product, GastroScreen, targeting pharmaceutical, biotech, food, and chemical industries. By offering a reliable biological model, Intero Biosystems aims to improve the accuracy of pre-clinical testing. This technology allows researchers to observe how various compounds interact with human tissue, potentially reducing risks and costs in development.
5Apate's Fraud Prevention Strategy
Finalist Apate, founded by Dali Kaafar, utilizes thousands of AI agents to combat digital fraud. These agents mimic human victims to bait scammers, answering calls and responding to phishing attempts. Beyond baiting, the company provides an insights portal offering analytics on scams targeting employees, brands, and products for its corporate clients.
6Historical Impact of Battlefield
Intero Biosystems joins a legacy of successful alumni including Trello, Discord, Cloudflare, and Mint. The program has hosted over 1,700 participants since its inception. Collectively, these alumni have raised more than $30 billion in funding and achieved over 200 successful exits, cementing the competition's status as a major startup industry milestone.
7Judging Panel Expertise Analysis
The final judging panel featured investors from firms like M13, Construct Capital, and Cherryrock Capital. Their evaluation criteria prioritized scalable business models and transformative technology. By involving active venture capitalists, the competition ensures that winners receive not only prize money but also significant visibility and potential access to future investment opportunities.
8Significance of the Victory
Winning the Startup Battlefield provides Intero Biosystems with significant industry validation and capital. As the biotech sector continues to seek efficient alternatives to traditional drug testing, the company's organoid technology addresses a critical market need. This recognition positions them for future growth as they scale their operations and expand their client base.
Original article: TechCrunch — Intero Biosystems Wins TechCrunch Startup Battlefield 2026